Drugs and Devices

FDA approves Raplixa to help control bleeding during surgery

On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. Raplixa is used to help control intraoperative bleeding. Read more.

Related Articles:

Leave a Reply

You have to agree to the comment policy.